Published in J Clin Microbiol on July 01, 1998
The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer (2002) 2.18
Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol (2010) 1.40
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. J Virol (2002) 1.35
Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J Virol (2008) 1.35
Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J Clin Microbiol (2008) 1.19
Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes. J Clin Microbiol (2001) 1.17
Baculovirus expression of chimeric hepatitis B virus core particles with hepatitis E virus epitopes and their use in a hepatitis E immunoassay. J Clin Microbiol (1999) 1.09
Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions. J Clin Microbiol (2002) 0.91
Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1. J Virol (2002) 0.91
The viral etiology of AIDS-associated malignancies. Adv Pharmacol (2008) 0.89
Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions. Clin Vaccine Immunol (2007) 0.88
Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications. Protein Sci (2009) 0.86
Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines. Infect Genet Evol (2013) 0.80
Human Papillomavirus Type16- L1 VLP Production in Insect Cells. Iran J Basic Med Sci (2013) 0.80
Prevalence of human papillomavirus variants and genetic diversity in the L1 gene and long control region of HPV16, HPV31, and HPV58 found in North-East Brazil. Biomed Res Int (2015) 0.79
Specificity of L1 peptides versus virus-like particles for detection of human papillomavirus-positive cervical lesions in females attending Engativa Hospital, Bogota, Colombia. J Clin Microbiol (2008) 0.77
Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies. J Transl Med (2010) 0.77
Variants of human papillomaviruses 16 (HPV16) in Uigur women in Xinjiang, China. Infect Agent Cancer (2016) 0.75
Comparative Genomics of Herpesviridae Family to Look for Potential Signatures of Human Infecting Strains. Int J Genomics (2016) 0.75
Human papillomavirus type 16 DNA sequence. Virology (1985) 9.44
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A (1992) 7.72
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol (1993) 5.12
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci U S A (1995) 4.15
Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol (1995) 4.14
Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys J (1991) 4.07
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J Virol (1996) 3.66
Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol (1993) 3.65
Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology (1991) 3.28
Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res (1989) 3.07
Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev (1997) 2.36
Antibody-mediated neutralization in vivo of infectious papillomaviruses. J Virol (1990) 2.34
Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution. Nat Struct Biol (1997) 2.30
Generation and neutralization of pseudovirions of human papillomavirus type 33. J Virol (1997) 2.29
The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol (1993) 2.27
Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J Virol (1990) 2.26
Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses. J Virol (1992) 1.88
Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol (1992) 1.80
Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. J Virol (1996) 1.66
Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology (1995) 1.65
Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly. J Virol (1997) 1.58
Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine (1995) 1.53
Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1. J Virol (1991) 1.49
Divergent human papillomavirus type 16 variants are serologically cross-reactive. J Infect Dis (1995) 1.17
Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbiol Lett (1994) 1.17
A formalin-inactivated vaccine protects against mucosal papillomavirus infection: a canine model. Pathobiology (1994) 1.15
Propagation of human papillomavirus type 11 in human xenografts using the severe combined immunodeficiency (SCID) mouse and comparison to the nude mouse model. Virology (1993) 1.09
Further observations on immunity to bovine cutaneous papillomatosis. Am J Vet Res (1960) 1.04
Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae. Gene (1996) 1.03
Human papillomaviruses: general features. Clin Dermatol (1997) 0.96
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01
Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin (2001) 3.65
Risk factors for cervical cancer in Colombia and Spain. Int J Cancer (1992) 2.75
Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer (1994) 2.74
Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol (1992) 2.60
Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev (1997) 2.36
Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33
Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet (1981) 2.31
Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer (1994) 2.23
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer (2001) 2.22
Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst (1998) 2.19
The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer (2002) 2.18
Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet (1986) 2.14
Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol (2000) 2.06
[Epidemiology and natural history of genital infection by human papillomavirus]. Gynecol Obstet Fertil (2002) 2.03
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer (2011) 1.96
Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst (1996) 1.96
Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95
Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer (1999) 1.91
Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res (2001) 1.85
Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83
International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer (2000) 1.79
Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer (2001) 1.75
Histologic types of gastric carcinoma in high- and low-risk areas. Int J Cancer (1968) 1.73
The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer (1998) 1.69
Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol (1996) 1.65
Cervical cancer. Cancer Surv (1994) 1.57
International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer (1998) 1.56
Penetrating colon injuries requiring resection: diversion or primary anastomosis? An AAST prospective multicenter study. J Trauma (2001) 1.56
Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis (1997) 1.56
Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev (1993) 1.56
Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies. Am J Epidemiol (1996) 1.55
Evidence for activation of cellular immune responses in patients with acute hepatitis E. Indian J Gastroenterol (2002) 1.54
Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst (1998) 1.53
Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Prog Med Virol (1981) 1.45
In vitro gene transfer using human papillomavirus-like particles. Nucleic Acids Res (1998) 1.44
Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America. Int J Cancer (2000) 1.42
Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res (1997) 1.42
Oral hygiene, dentition, sexual habits and risk of oral cancer. Br J Cancer (2000) 1.41
HPV types and cofactors causing cervical cancer in Peru. Br J Cancer (2001) 1.41
Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer (2009) 1.40
Mate drinking, alcohol, tobacco, diet, and esophageal cancer in Uruguay. Cancer Res (1990) 1.39
Health-related quality of life of patients with HIV: impact of sociodemographic, clinical and psychosocial factors. Qual Life Res (2005) 1.39
Precursor lesions of oesophageal cancer in young people in a high-risk population in China. Lancet (1989) 1.38
Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer (2000) 1.36
Immunisation against hepatitis B in man. Lancet (1976) 1.31
High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. Sex Transm Dis (2001) 1.30
Typing of urogenital, maternal, and neonatal isolates of Haemophilus influenzae and Haemophilus parainfluenzae in correlation with clinical source of isolation and evidence for a genital specificity of H. influenzae biotype IV. J Clin Microbiol (1989) 1.29
Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis (1995) 1.27
[Oncogenic human papillomaviruses in extra-genital Bowen disease revealed by in situ hybridization]. Ann Dermatol Venereol (2001) 1.26
Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP16. J Gen Virol (2000) 1.25
Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer (1994) 1.24
Time trends of intestinal and diffuse types of gastric cancer in Norway. Int J Cancer (1971) 1.24
Prevalence of adverse reproductive outcomes in a population occupationally exposed to pesticides in Colombia. Scand J Work Environ Health (1990) 1.23
Time trends of intestinal and diffuse types of gastric cancer in the United States. Int J Cancer (1971) 1.22
Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol (1987) 1.21
Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect (2006) 1.21
Identification of a novel hepatitis E virus in Nigeria. J Gen Virol (2000) 1.21
Histological detection of messenger RNAs with biotinylated synthetic oligonucleotide probes. J Histochem Cytochem (1988) 1.20
Social differences in sexual behaviour and cervical cancer. IARC Sci Publ (1997) 1.20
Hot beverages and oesophageal cancer in southern Brazil: a case-control study. Int J Cancer (1987) 1.19
Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev (1996) 1.19
Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate. FEMS Microbiol Lett (2001) 1.19
Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions. J Clin Virol (2005) 1.19
Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology (1992) 1.18
Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes. J Clin Microbiol (2001) 1.17
Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun (2001) 1.17
Hepatitis B virus DNA in primary hepatocellular carcinoma tissue. J Med Virol (1978) 1.17
Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbiol Lett (1994) 1.17
Electron microscopy of Staphylococcus aureus cell wall lysis. J Bacteriol (1966) 1.17
Human papillomavirus vaccines. Semin Cancer Biol (1999) 1.13
Alcohol, tobacco, diet, mate drinking, and esophageal cancer in Argentina. Cancer Epidemiol Biomarkers Prev (1995) 1.13
Serologic response in human papillomavirus-associated invasive cervical cancer. Int J Cancer (1993) 1.13
Infectious mononucleosis and Hodgkin's disease. Int J Cancer (1978) 1.13
Active immunization against hepatitis B in an area of high endemicity. Part I: Field design. Prog Med Virol (1981) 1.12
Nutritional factors in colorectal cancer risk: a case-control study in Majorca. Int J Cancer (1991) 1.12
Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells. J Gen Virol (2001) 1.12
Biological and molecular features of the relationships between Diadromus pulchellus ascovirus, a parasitoid hymenopteran wasp (Diadromus pulchellus) and its lepidopteran host, Acrolepiopsis assectella. J Gen Virol (1997) 1.12
Immune response in neonates to hepatitis B vaccine. Lancet (1982) 1.11
[Hepatitis B virus and primary liver carcinoma: evidences for a filiation hepatitis B, cirrhosis and primary liver cancer]. Ann Microbiol (Paris) (1977) 1.10
p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Am J Pathol (1993) 1.09
Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease. Clin Cancer Res (2000) 1.09
Baculovirus expression of chimeric hepatitis B virus core particles with hepatitis E virus epitopes and their use in a hepatitis E immunoassay. J Clin Microbiol (1999) 1.09
Hot and cold mate drinking and esophageal cancer in Paraguay. Cancer Epidemiol Biomarkers Prev (1995) 1.08
Identification of the glycoprotein 41(TM) cytoplasmic tail domains of human immunodeficiency virus type 1 that interact with Pr55Gag particles. AIDS Res Hum Retroviruses (2000) 1.07
Arteritis of the aorta and its major branches. Am Heart J (1970) 1.07
Hepatitis E virus infection in Turkey. Lancet (1993) 1.07
African strains of hepatitis E virus that are distinct from Asian strains. J Med Virol (1997) 1.07
Birth defects among children born to a population occupationally exposed to pesticides in Colombia. Scand J Work Environ Health (1990) 1.05
Tobacco smoking, occupational exposure and bladder cancer in Argentina. Int J Cancer (1987) 1.05